ABT β€” Abbott Laboratories

Ownership history in ANTIPODES PARTNERS Ltd  Β·  3 quarters on record

This page tracks every 13F SEC filing in which ANTIPODES PARTNERS Ltd reported a position in Abbott Laboratories (ABT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.01% (2025 Q1)
πŸ“Š Avg. % of fund
0.0%
πŸ“… First filed
2025 Q1
πŸ“… Last filed
2025 Q3
⏱ Quarters held
3

Position Intelligence

ANTIPODES PARTNERS Ltd Γ— ABT AI Analytics

πŸ“‰ ANTIPODES PARTNERS Ltd underperformed the S&P 500 by –34.0% annually on this ABT position. Average cost basis: $130.37. Maximum drawdown during holding period: –1.1%.

πŸ“ˆ Position Alpha vs SPY
-34.0%
annualised excess return

❌ Significantly underperformed the S&P 500 by 34.0% ann.
2 quarters analyzed

πŸ’° Entry Quality
$130.37
+1.8% vs current ($132.67)

Best entry: $130.21 (2025 Q1)  Β·  Worst: $132.67 (2025 Q3)

πŸ›‘οΈ Drawdown Resilience
–1.1%
max drawdown while held

πŸ’Ž No drawdown exceeding 20% during the holding period β€” exceptionally stable.

πŸ’ͺ Fund Conviction
67%
buy-side decisions

2 adds Β· 1 trim. Bought during 1 of 1 down-price quarters. πŸ“ˆ More buys than sells across the holding period.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.0% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    ABT price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 3 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 828 +87 +11.7% 0.00% $111K $132.67
2025 Q2 REDUCED 741 -529 -41.7% 0.00% $101K $134.12
2025 Q1 INITIATED 1,270 β€” β€” 0.01% $168K $130.21

🏒 Other funds also holding ABT

As of 2025 Q4 β€” sorted by position size

Livelsberger Financial Advisory 16.33% CURA WEALTH ADVISORS, LLC 10.82% PATRICK M SWEENEY & ASSOCIATES, INC 5.83% Sugar Maple Asset Management, LLC 5.64% Milestone Resources Group Ltd 3Y 7Y 5.58% COERENTE CAPITAL MANAGEMENT 3Y 5.06% Tandem Investment Advisors, Inc. 3Y 7Y 4.63% America First Investment Advisors, LLC 3Y 7Y 4.54% HENDLEY & CO INC 3Y 7Y 4.45% Bruce & Co., Inc. 3Y 7Y 4.42%
← Back to ANTIPODES PARTNERS Ltd Holdings